Continuing Education Credits
Continuing Education Credit amounts are subject to change.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASTRO designates this other activity (hybrid meeting) for a maximum of 217 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
An application to the Medical Dosimetrist Certification Board will be submitted for MDCB credits.
An application will be submitted for Category A/A+ CE credit for approval by the American Society for Radiologic Technologists.
This activity has been approved for a maximum of 210.3 Medical Physics Continuing Education Credits (MPCEC) by the Commission on Accreditation of Medical Physics Education Programs (CAMPEP).
This activity is not approved for nursing CEUs.
Maintenance of Certification
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 217 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosure of Vested Interest
ASTRO is an accredited provider of continuing medical education. Since our accreditation is important to us, we plan activities that are compliant with the ACCME and the content or format of CME activities and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias. Planning Committee members and speakers are required to disclose the existence of any financial or other relationship with the manufacturer(s) of any commercial product(s) or provider(s) of any commercial services discussed in an educational presentation.
Any conflicts of interest are resolved prior to participation. In addition to written disclosure, presenters will disclose any vested interest or their intention to discuss off-label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation and in accordance with the Accreditation Council for Continuing Medical Education standards and the Food and Drug Administration requirements.
In an effort to increase transparency and easy access to all disclosures, ASTRO's Faculty, Committee and Planner disclosure information will be available online for the 2020 Annual Meeting. Go to the ASTRO Annual Meeting Program web page. In addition, disclosure slides will be shown at the beginning of each session and every presenter is also required to display their disclosure. Disclosure information will not be printed in paper versions of the meeting materials.
ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.